Possible ordersValneva is also in discussions with the European Commission, Canada and Australia about possible orders.
There have been no talks with the U.S., which is the only country not looking at an inactivated vaccine candidate, Lingelbach said.Valneva is using the same technology applied to its Japanese Encephalitis vaccine, the only shot that exists against the disease.
A number of Chinese drugmakers, including Beijing-based Sinovac Biotech Ltd., are also working on inactivated Covid-19 vaccines.Lingelbach said any profit from the company’s SARS-CoV-2 shot would probably be marginal, but the focus on vaccines and accelerated development timelines as a result of the pandemic could benefit the company longer term.